Cempra Inc (NASDAQ:CEMP)

9.42
Data as of Jul 24
 -0.15 / -1.57%
Today’s Change
7.67
Today|||52-Week Range
15.39
-23.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$317.7M

Company Description

Cempra, Inc. is a clinical-stage pharmaceutical company. It focuses on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. The company intends to utilize its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. It has two antibiotic candidates: Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC.

Contact Information

Cempra, Inc.
Building Two Quadrangle
Chapel Hill North Carolina 27517-8149
P:(919) 313-6601
Investor Relations:

Employees

Shareholders

Individual stakeholders37.95%
Other institutional29.18%
Mutual fund holders22.85%

Top Executives

Prabhavathi B. FernandesPresident, Chief Executive Officer & Director
Mark W. HahnChief Financial Officer & Executive Vice President
David OldachSenior Vice President-Clinical Research
David S. MooreChief Commercial Officer & Executive VP
David PereiraSenior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.